Tosoh International DMC BranchZ4.C20Tosoh Bioscience-Diagnostics is part of the Specialty division of Tosoh Corporation, a multi-national chemical company, present in 140 countries, employing 12,000 people. It is an acknowledged global leader in the diagnostic market and field of liquid chromatography. Tosoh has throughout the years demonstrated technological leadership in Immunochemistry, HPLC-based diabetes and Thalassemia screening as well as molecular testing solutions. These support the diagnosis and monitoring of life-threatening disease as diabetes, certain cancers and infections diseases among many others.
At the EuroMedLab 2023 Tosoh will launch the AIA®-CL300, its new Automated Chemiluminescent Enzyme Immunoassay Analyzer. This “Small Giant” is a flexible solutions to meet laboratories’ and hospitals’ specific needs. With its new design and compactness, AIA-CL300 sets new standards in terms of usability and result precision leading to better patient outcomes and treatments. The AIA-CL300 adds-on to the existing Tosoh Immunoassay Analyzer range, widely known for their reliability and analytical performance.
